Article Details

Roche Alzheimer's Disease Assays Obtain FDA 510(k) Clearance - 360Dx

Retrieved on: 2022-12-08 14:49:57

Tags for this article:

Click the tags to see associated articles and topics

Roche Alzheimer's Disease Assays Obtain FDA 510(k) Clearance - 360Dx. View article details on hiswai:

Excerpt

The two cerebrospinal fluid-based Elecsys tests will be available on Roche's Cobas immunoassay analyzers.

Article found on: www.360dx.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up